Aronia berry (Aronia mitschurinii ‘Viking’) inhibits colitis in mice and inhibits T cell tumour necrosis factor-α secretion
2018
Abstract Aronia berries are rich in polyphenols with anti-inflammatory activity. We hypothesized that aronia berry consumption modulates intestinal immune function and T cells. The aims of the present work were to assess the immunomodulatory potential of ‘Viking’ aronia berry (black chokeberry, Aronia mitschurinii ) in vivo and to determine the extent aronia berry polyphenols or known microbial polyphenol catabolites inhibit T cell tumour necrosis factor (TNF)-α in vitro . Aronia berry consumption increased colonic IL-10 secretion in healthy mice, but did not inhibit ex vivo cytokine secretion of lipopolysaccharide-stimulated spleen and colon tissue. Aronia berry consumption inhibited wasting associated with T cell adoptive transfer and dextran sulphate sodium induced colitis. Aronia extracts, neutral phenols fraction, and the polyphenol catabolites 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxyphenylpropionic acid inhibited TNF-α production in Jurkat T cells. Therefore, T cells and microbial catabolism partly mediate the anti-inflammatory effects of aronia consumption in the colon.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
40
References
12
Citations
NaN
KQI